Business
US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News
The US Food and Drug Administration approves Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and…
The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.
- The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
- However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
- Remdesivir will be sold…
-
Noosa News20 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General19 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News22 hours agoPeter Dutton insists there’s enough water for his seven nuclear plants, contradicting shadow frontbencher
-
General21 hours agoCanberra man named as doctor accused of rape after suppression order lifted